These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

105 related articles for article (PubMed ID: 2880333)

  • 1. [Comparative effects of somatostatin and ranitidine on gastric function in children with hyperchlorhydria].
    Socha J; Rasiński A; Cichy W; Chojnacki J; Bogoniowska Z
    Pediatr Pol; 1986 Jun; 61(6):337-44. PubMed ID: 2880333
    [No Abstract]   [Full Text] [Related]  

  • 2. Drug therapy for peptic ulcer disease.
    Voirin J
    Am Fam Physician; 1984 Dec; 30(6):154-9. PubMed ID: 6095630
    [No Abstract]   [Full Text] [Related]  

  • 3. Ranitidine in children with peptic ulcer and patients with pancreatic cystic fibrosis.
    Scorza A; Conti-Nibali S; Sferlazzas C; Saitta G; Tedeschi A
    Int J Clin Pharmacol Res; 1990; 10(3):179-82. PubMed ID: 2228343
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Importance of acid secretion inhibition in peptic ulcer treatment].
    Med Clin (Barc); 1990 Mar; 94(8):suppl 2 p.. PubMed ID: 2342387
    [No Abstract]   [Full Text] [Related]  

  • 5. Suppression of gastric acidity in horses.
    Murray MJ
    J Am Vet Med Assoc; 1997 Jul; 211(1):37-40. PubMed ID: 9215408
    [No Abstract]   [Full Text] [Related]  

  • 6. [Effect of somatostatin and ranitidine in acute hemorrhage of the upper digestive tract].
    Jorge AD
    Acta Gastroenterol Latinoam; 1989; 19(1):3-14. PubMed ID: 2574930
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Synthetic analog of prostaglandin E2 (enprostil) in the treatment of peptic ulcer].
    Grigor'ev PIa; Isakov VA
    Sov Med; 1991; (3):39-43. PubMed ID: 1909055
    [No Abstract]   [Full Text] [Related]  

  • 8. Effects of the novel histamine H2-receptor antagonist (+/-)-(E)-1-[2-hydroxy-2-(4-hydroxyphenyl)ethyl]-3-[2-[[[5- (methylamino)methyl-2-furyl]methyl]thio]ethyl]-2-(methylsulfonyl) guanidine on gastric secretion and gastroduodenal ulcers in rats.
    Amagase K; Kato S; Yamamoto H; Okabe S
    Arzneimittelforschung; 1996 Feb; 46(2):177-84. PubMed ID: 8720310
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The magnitude of nocturnal acid suppression by ranitidine 300 mg given at 18.00 hours.
    Ovartlarnporn B; Prichaworawach S; Niyomthai N; Wuthi S; Chamsai M; Tansakool U
    J Med Assoc Thai; 1992 Feb; 75(2):110-5. PubMed ID: 1645048
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effects of ranitidine or nocloprost on the selected gastric juice components in the patients with the gastric ulcer.
    Skrodzka D; Gabryelewicz A
    Rocz Akad Med Bialymst; 1997; 42(1):257-66. PubMed ID: 9581490
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Smoking, gastric acid secretion duodenal ulcer healing, and H2 receptor antagonists.
    Pal LS; Chander B; Sharma A
    J Assoc Physicians India; 1989 Jul; 37(7):476-7. PubMed ID: 2613670
    [No Abstract]   [Full Text] [Related]  

  • 12. Ranitidine: a new H2-receptor antagonist.
    Zeldis JB; Friedman LS; Isselbacher KJ
    N Engl J Med; 1983 Dec; 309(22):1368-73. PubMed ID: 6314139
    [No Abstract]   [Full Text] [Related]  

  • 13. [Microcirculation in gastric mucosa as related to its secretory activity in patients with peptic ulcer].
    Shcherbynina MB
    Lik Sprava; 2002; (5-6):24-6. PubMed ID: 12442513
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Peptic ulcer disease.
    Hawker P
    Practitioner; 1989 May; 233(1469):769-70, 773. PubMed ID: 2602318
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Mechanism of recurrence and relapse in peptic ulcer after drug therapy; gastric juice and gastric acid secretion].
    Nakaizumi A; Iishi H; Tatsuta M; Okuda S
    Nihon Rinsho; 1988 Jan; 46(1):102-6. PubMed ID: 2897480
    [No Abstract]   [Full Text] [Related]  

  • 16. Acid suppression as treatment for NSAID-related peptic ulcers.
    Howden CW; Holt S
    Am J Gastroenterol; 1991 Dec; 86(12):1720-2. PubMed ID: 1962615
    [No Abstract]   [Full Text] [Related]  

  • 17. [Is strong inhibition of gastric acid in the treatment of peptic ulcer sensible?].
    de Bruijne JW; Lamers CB
    Ned Tijdschr Geneeskd; 1989 Apr; 133(13):657-62. PubMed ID: 2566125
    [No Abstract]   [Full Text] [Related]  

  • 18. [Recent state of therapy of peptic disease].
    Pavlotzky M; Eshchar J
    Harefuah; 1985 Nov; 109(10):288-96. PubMed ID: 3912295
    [No Abstract]   [Full Text] [Related]  

  • 19. Acid rules--or does it?
    Misiewicz JJ
    J Clin Gastroenterol; 1986 Jun; 8(3 Pt 2):323-5. PubMed ID: 2876023
    [No Abstract]   [Full Text] [Related]  

  • 20. [Histamine H2 receptor blockaders: possibilities and prognosis in the use of stage III-IV preparations in the therapy of internal diseases].
    Miagkova LP; Grebenev AL; Kkhorshed AM
    Klin Med (Mosk); 1991 Mar; 69(3):27-34. PubMed ID: 1676773
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.